ICON plans UK investment, Verum expands in the US, plus updates from Charles River, Phlexglobal, Accenture/Octagon and Quanticate.
A round-up of developments in the contract research sector, including updates on Charles River Labs, ShangPharma, Icon, Covance, AAIPharma and …
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals

